Huub Schellekens is Professor in the Department of Pharmaceutical Sciences and Innovation Studies at Utrecht University, The Netherlands.
What Is Hindering The Uptake Of Biosimilars?
The biggest differences between the development of a biosimilar and a generic medicine lie primarily in the preclinical and clinical stages.